Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, United States.
Front Immunol. 2022 Jan 27;13:840923. doi: 10.3389/fimmu.2022.840923. eCollection 2022.
Oral premalignant lesions (OPLs) are the precursors to oral cavity cancers, and have variable rates of progression to invasive disease. As an intermediate state, OPLs have acquired a subset of the genomic alterations while arising in an oral inflammatory environment. These specific genomic changes may facilitate the transition to an immune microenvironment that permits malignant transformation. Here, we will discuss mechanisms by which OPLs develop an immunosuppressive microenvironment that facilitates progression to invasive cancer. We will describe how genomic alterations and immune microenvironmental changes co-evolve and cooperate to promote OSCC progression. Finally, we will describe how these immune microenvironmental changes provide specific and unique evolutionary vulnerabilities for targeted therapies. Therefore, understanding the genomic changes that drive immunosuppressive microenvironments may eventually translate into novel biomarker and/or therapeutic approaches to limit the progression of OPLs to potential lethal oral cancers.
口腔癌前病变(OPLs)是口腔癌的前体,其向侵袭性疾病进展的比率各不相同。作为一种中间状态,OPLs 在口腔炎症环境中产生的同时获得了一部分基因组改变。这些特定的基因组变化可能有助于过渡到允许恶性转化的免疫微环境。在这里,我们将讨论 OPLs 如何发展出免疫抑制微环境以促进侵袭性癌症进展的机制。我们将描述基因组改变和免疫微环境变化如何共同进化和合作以促进 OSCC 进展。最后,我们将描述这些免疫微环境变化如何为靶向治疗提供特定且独特的进化弱点。因此,了解驱动免疫抑制微环境的基因组变化最终可能转化为新的生物标志物和/或治疗方法,以限制 OPL 向潜在致命性口腔癌的进展。